Phase I: Solid tumors
FOCUS AREA
SOLID TUMORS
DEVELOPMENT STAGE
PHASE I
TARGET
7
17
Title
SIRPα antagonist (BI 765063) + ezabenlimab
Order
17
Subtitle pipeline
Combination
SEO Description
SIRPα antagonist (BI 765063) + ezabenlimab